+44 (0)844 736 9016     info@mawdsleys.com    LinkedIn

For more information
about our services 
email us here

Controlled Access Programmes

Ensuring that no medicines are unavailable to patients who need them.

In 2004, Mawdsleys started a dedicated business focused on providing fully managed and regulatory compliant access for physicians and their patients to medicines that are not approved in the UK. Since then, Mawdsleys have expanded this service to offer the same access opportunities to physicians worldwide as well as working directly with pharmaceutical companies to ensure that their products can be accessed wherever a patient’s unmet clinical need requires it.

Mawdsleys provide a regulatory compliant and cost effective solution for pharmaceutical and biotech companies to make medicines available to patients where no licensed treatment option exists in their country. Examples of why patients may not have a licensed treatment option include where a medicine is new and has not yet been approved in their country, because a clinical trial in which they have been enrolled is finishing or because a previously licensed medicine has been discontinued.

In all these cases, Mawdsleys can provide a bespoke, turnkey solution which will provide patients with quick and secure access to the medicines they need.

By centralising access for patients through Mawdsleys, the pharmaceutical company will gain full visibility of demand as well as control of the information which passes to and from the healthcare provider. This access will be fully controlled by Mawdsleys in accordance with the particular commercial and clinical parameters agreed with the pharmaceutical company.

 

For more information pharmaceutical and biopharmaceutical companies should e-mail info@mawdsleys.com

Helping ensure patients have access to the drugs they need, when they need them.

Mawdsleys Worldwide

Select from the following Worldwide sites...

×